Bond.az White LogoBond.az Black Logo

American Healthcare REIT prices $705.6M stock offering

American Healthcare REIT prices 14 million share offering at $705.6 million. BofA Securities underwrites the deal.

Lucas Garcia
ByLucas Garcia- Senior Editor
|
0

IRVINE, Calif. - American Healthcare REIT, Inc. (NYSE:AHR) announced today the pricing of an underwritten public offering of 14 million shares of its common stock, according to a press release. The offering is expected to generate gross proceeds of approximately $705.6 million before expenses.

The timing of this offering comes as AHR shares trade at $51.68, near their 52-week high of $54.67, following a remarkable 54.85% return over the past year.

The offering is expected to close Friday, subject to customary closing conditions. BofA Securities is acting as the underwriter for the offering.

The company entered into a forward sale agreement with BofA Securities or an affiliate with respect to the 14 million shares. Under the agreement, the forward purchaser or its affiliate is expected to borrow shares from third parties and sell them to the underwriter.

The underwriter has been granted a 30-day option to purchase up to an additional 2.1 million shares. If exercised, the company expects to enter into an additional forward sale agreement for those shares, bringing the total potential offering to 16.1 million shares.

The company will not receive proceeds from the initial sale of shares by the forward purchaser. The company expects to physically settle the forward sale agreement within approximately 24 months from the prospectus supplement date.

The company expects to contribute net proceeds from the settlement to its operating partnership in exchange for OP Units. The operating partnership is expected to use the proceeds for general corporate purposes, including potential future investments.

American Healthcare REIT is a real estate investment trust that owns and operates clinical healthcare real estate, focusing on senior housing, skilled nursing facilities, and outpatient medical buildings in the US, UK, and Isle of Man. The company generated revenue of $2.37 billion over the last twelve months with 12.68% growth, while maintaining profitability with earnings per share of $0.58.

More News
2026-06-01 12:34
|
401

Amber International shareholder to distribute stake pro rata

Amber International's principal shareholder distributes all Class A shares pro rata to existing shareholders; market impact and financial highlights.

0
2026-06-01 12:33
|
213

Palladyne AI Adds Two Retired Generals to Board

Palladyne AI appoints two retired generals to its defense advisory board. Stock up 98% YTD.

0
2026-06-01 12:32
|
381

Cellectar Plans Phase 3 Trial for WM After BTKi

Cellectar Biosciences reports promising Phase 2 results for iopofosine I 131 in Waldenström macroglobulinemia after BTKi therapy, plans Phase 3 trial.

0
2026-06-01 11:33
|
363

essensys Shareholders Approve Re-Registration as Private Company

essensys shareholders approve re-registration as a private company after AIM delisting. All voting shareholders backed the resolution.

0
2026-06-01 08:31
|
889

Causeway Capital Boosts Melrose Stake to 5.12%

Causeway Capital increased its stake in Melrose Industries to 5.12%. The investment firm now holds over 63 million voting rights.

0
2026-06-01 08:03
|
968

Ignitis grupė starts search for new CEO

Ignitis grupė launches CEO search in Lithuania. Learn about requirements and application deadline for the new CEO position.

0
2026-06-01 07:33
|
417

Aquila Renewables: Adviser Withholds Fee Data

Aquila European Renewables says its investment adviser Aquila Capital has not provided complete fee information. The Board is considering legal action.

0
2026-06-01 07:31
|
226

USA Rare Earth Plans €175M France Investment

USA Rare Earth reveals €175 million investment plan in France for metal, alloy and magnet manufacturing, aiming to create over 300 jobs by 2030.

0
2026-06-01 07:30
|
761

Lucid Group Names Silvio Napoli CEO

Lucid Group appoints Silvio Napoli as CEO effective immediately. Stock up 12% in past week but down 38% YTD. Company faces financial challenges.

0
2026-06-01 07:04
|
679

Mkango Reports Q1 2026 Financial Results

Mkango Resources reports Q1 2026 financial results. Details on rare earth projects, recycling operations, and SPAC merger.

0
2026-06-01 07:02
|
274

Greatland secures $500m debt facility, OKs Havieron

Greatland Resources secures $500 million corporate debt facility and board approval for Havieron gold-copper project final investment decision.

0
2026-06-01 07:00
|
542

Calnex director buys shares at 69.9p

Calnex Solutions non-executive director Graeme Bissett buys 28,610 shares at 69.9p each on the London Stock Exchange.

0
...